JIPLP: So when is a patent claim too broad?
The Journal of Intellectual Property Law and Practice has published an article by Andrew Sharples and Carissa Kendall-Palmer about the Court of Appeal’s decision in Regeneron Pharmaceuticals Inc v Genentech Inc.
This ruling confirms that a broad claim in a patent encompassing a large number of unexemplified embodiments can be valid and enforceable.
To read the JIPLP article in full, click here.